{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:01:52Z","timestamp":1790319712794,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejpn.2013.11.002","type":"journal-article","created":{"date-parts":[[2013,11,10]],"date-time":"2013-11-10T14:45:28Z","timestamp":1384094728000},"page":"171-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Onabotulinumtoxin A\u00ae injections: A safety review of children with clubfoot under 2 years of age at BC Children's Hospital"],"prefix":"10.1016","volume":"18","author":[{"given":"Harpreet","family":"Chhina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Howren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-5580","authenticated-orcid":false,"given":"Andrea","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2013.11.002_bib1","series-title":"Product monograph","author":"Allergan","year":"2011"},{"key":"10.1016\/j.ejpn.2013.11.002_bib2","series-title":"Botulinum neurotoxin and tetanus toxin","author":"Simpson","year":"1989"},{"issue":"1","key":"10.1016\/j.ejpn.2013.11.002_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in Botulinum Toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ejpn.2013.11.002_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139.5","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"issue":"3, Part 1","key":"10.1016\/j.ejpn.2013.11.002_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ejpn.2013.11.002_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"issue":"2, Part 1","key":"10.1016\/j.ejpn.2013.11.002_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/j.ejpn.2013.11.002_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-8749.2012.04370.x","article-title":"Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review","volume":"54","author":"Rodwell","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2013.11.002_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1469-8749.2009.03583.x","article-title":"Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy","volume":"52","author":"Naidu","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.ejpn.2013.11.002_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2310\/7010.2006.00041","article-title":"Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity","volume":"21","author":"Goldstein","year":"2006","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.ejpn.2013.11.002_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0269215508099860","article-title":"Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials","volume":"23","author":"Albavera-Hern\u00c3\u00a1ndez","year":"2009","journal-title":"Clin Rehabil"},{"issue":"6","key":"10.1016\/j.ejpn.2013.11.002_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jaad.2005.08.036","article-title":"Adverse event reporting for botulinum toxin type A","volume":"53","author":"Batra","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.ejpn.2013.11.002_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.phm.0000179516.45373.c4","article-title":"Botulinum toxin type a in the treatment of children with congenital muscular torticollis","volume":"84","author":"Oleszek","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.ejpn.2013.11.002_bib14","series-title":"Safety of botulinum toxin type A: a systematic review and meta-analysis","first-page":"981","author":"Naumann","year":"2004"},{"issue":"3","key":"10.1016\/j.ejpn.2013.11.002_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","volume":"53","author":"Cot\u00e9","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ejpn.2013.11.002_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ejpn.2008.10.006","article-title":"Safety of botulinum toxin type A in children younger than 2 years","volume":"13","author":"Pascual-Pascual","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2013.11.002_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.bpo.0000149861.50400.db","article-title":"Treatment of idiopathic clubfoot utilizing botulinum A toxin: a new method and its short-term outcomes","volume":"25","author":"Alvarez","year":"2005","journal-title":"J Pediatr Orthop"},{"issue":"6","key":"10.1016\/j.ejpn.2013.11.002_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/BPO.0b013e3181b2b3d4","article-title":"The use of botulinum type a toxin in the treatment of idiopathic clubfoot: 5-year follow-up","volume":"29","author":"Alvarez","year":"2009","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.ejpn.2013.11.002_bib19","series-title":"Congenital clubfoot: fundamentals of treatment","author":"Ponseti","year":"1996"},{"issue":"5","key":"10.1016\/j.ejpn.2013.11.002_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s11999-008-0702-9","article-title":"Gait analysis after initial nonoperative treatment for clubfeet: intermediate term followup at age 5","volume":"467","author":"Karol","year":"2009","journal-title":"Clin Orthopaedics Relat Research\u00ae"},{"key":"10.1016\/j.ejpn.2013.11.002_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/BPO.0b013e3181b76a5f","article-title":"Ultrasonographic evaluation of achilles tendon repair after percutaneous sectioning for the correction of congenital clubfoot residual equinus","author":"Maranho","year":"2009","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"10.1016\/j.ejpn.2013.11.002_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00776-012-0312-y","article-title":"Ultrasonographic observation of the healing process in the gap after a Ponseti-type Achilles tenotomy for idiopathic congenital clubfoot at two-year follow-up","volume":"18","author":"Niki","year":"2012","journal-title":"J Orthop Sci"},{"issue":"4","key":"10.1016\/j.ejpn.2013.11.002_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/03635465000280040901","article-title":"Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type III collagen than tenocytes from normal achilles tendons. An in\u00a0vitro model of human tendon healing","volume":"28","author":"Maffulli","year":"2000","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.ejpn.2013.11.002_bib24","series-title":"Normal accidents: living with high risk technologies","author":"Perrow","year":"1984"},{"issue":"11","key":"10.1016\/j.ejpn.2013.11.002_bib25","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1503\/cmaj.1040498","article-title":"The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada","volume":"170","author":"Baker","year":"2004","journal-title":"CMAJ Can Med Assoc J\u00a0=\u00a0Journal De L'association Medicale Canadienne"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T23:58:10Z","timestamp":1647043090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379813001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1090379813001773"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.11.002","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onabotulinumtoxin A\u00ae injections: A safety review of children with clubfoot under 2 years of age at BC Children's Hospital","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}